THERAPEUTIC FOCUS
We focus on development of novel and breakthrough therapies for unmet medical needs in any therapeutic area where a scientific, medical and business opportunity arises.
Areas of our interest are:
- Orphan diseases
- Immune and autoimmune diseases
- Cancer
- Neurological disorders
Currently we have under development a drug for a serious autoimmune condition:
AUR-1001 is the first in class compound for the treatment of Antiphospholipid Syndrome (Hughes syndrome)
DRUG DEVELOPMENT MODEL
BUSINESS MODEL
